Long-term impact of hypothyroidism during gestation and lactation on the mammary gland

Abstract The functional differentiation of the mammary gland (MG) is fundamental for the prevention of mammary pathologies. This process occurs throughout pregnancy and lactation, making these stages key events for the study of pathologies associated with development and differentiation. Many studies have investigated the link between mammary pathologies and thyroid diseases, but most have ignored the role of thyroid hormone (TH) in the functional differentiation of the MG. In this work, we show the long-term impact of hypothyroidism in an animal model whose lactogenic differentiation occurred at low TH levels. We evaluated the ability of the MG to respond to hormonal control and regulate cell cycle progression. We found that a deficit in TH throughout pregnancy and lactation induces a long-term decrease in Rb phosphorylation, increases p53, p21, Cyclin D1 and Ki67 expression, reduces progesterone receptor expression, and induces nonmalignant lesions in mammary tissue. This paper shows the importance of TH level control during mammary differentiation and its long-term impact on mammary function.

[1]  Cecilia J. Proietti,et al.  Molecular mechanisms underlying progesterone receptor action in breast cancer: Insights into cell proliferation and stem cell regulation , 2019, Steroids.

[2]  T. López del Val,et al.  Slightly elevated thyrotropin levels in pregnancy in our clinical practice. , 2019, Endocrinologia, diabetes y nutricion.

[3]  T. Ludwig,et al.  Abrupt involution induces inflammation, estrogenic signaling, and hyperplasia linking lack of breastfeeding with increased risk of breast cancer , 2019, Breast Cancer Research.

[4]  A. Feizi,et al.  Thyroid‐stimulating hormone (TSH) serum levels and risk of spontaneous abortion: A prospective population‐based cohort study , 2019, Clinical endocrinology.

[5]  O. Dekkers,et al.  Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study , 2019, Breast Cancer Research.

[6]  L. Tian,et al.  Hypothyroidism and related diseases: a methodological quality assessment of meta-analysis , 2019, BMJ Open.

[7]  A. Feizi,et al.  Reference Intervals for Thyroid Hormones During the First Trimester of Gestation: A Report from an Area with a Sufficient Iodine Level , 2019, Hormone and Metabolic Research.

[8]  M. Rotondi,et al.  Thyroid hormone therapy for subclinical hypothyroidism , 2019, Endocrine.

[9]  S. Pearce,et al.  Thyroid Hormone Therapy for Subclinical Hypothyroidism. , 2019, JAMA.

[10]  Jianhua Zhou,et al.  Analysis of detection results of thyroid function-related indexes in pregnant women and establishment of the reference interval , 2018, Experimental and therapeutic medicine.

[11]  P. Margozzini,et al.  Thyroid-Stimulating Hormone Reference Ranges in the First Trimester of Pregnancy in an Iodine-Sufficient Country , 2018, Endocrinology and metabolism.

[12]  S. Spencer,et al.  Control of the Restriction Point by Rb and p21 , 2018, Proceedings of the National Academy of Sciences.

[13]  S. Ingles,et al.  Reproductive history, breast‐feeding and risk of triple negative breast cancer: The Breast Cancer Etiology in Minorities (BEM) study , 2018, International journal of cancer.

[14]  S. Mousa,et al.  Thyroid Hormone in the Clinic and Breast Cancer , 2018, Hormones and Cancer.

[15]  F. A. Persia,et al.  Hypothyroidism decreases JAK/STAT signaling pathway in lactating rat mammary gland , 2017, Molecular and Cellular Endocrinology.

[16]  R. Carón,et al.  Hypothyroidism reduces mammary tumor progression via Β-catenin-activated intrinsic apoptotic pathway in rats , 2017, Histochemistry and Cell Biology.

[17]  P. Tao,et al.  BMI, reproductive factors, and breast cancer molecular subtypes: A case-control study and meta-analysis , 2016, Journal of epidemiology.

[18]  L. Santoro,et al.  Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies. , 2016, Cancer treatment reviews.

[19]  J. Russo Reproductive history and breast cancer prevention , 2016, Hormone molecular biology and clinical investigation.

[20]  P. Davis,et al.  Thyroid Hormone, Cancer, and Apoptosis. , 2016, Comprehensive Physiology.

[21]  J. Visvader,et al.  Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer , 2016, Oncogene.

[22]  J. Serra-Musach,et al.  Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation , 2016, Stem cells.

[23]  H. Sørensen,et al.  Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study. , 2016, European journal of endocrinology.

[24]  R. Carón,et al.  Hypothyroidism advances mammary involution in lactating rats through inhibition of PRL signaling and induction of LIF/STAT3 mRNAs , 2016, Molecular and Cellular Endocrinology.

[25]  H. Anders,et al.  Cell cycle control in the kidney. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  L. Marasco Unsolved Mysteries of the Human Mammary Gland: Defining and Redefining the Critical Questions from the Lactation Consultant’s Perspective , 2014, Journal of Mammary Gland Biology and Neoplasia.

[27]  K. Poppe,et al.  An international survey of screening and management of hypothyroidism during pregnancy in Latin America. , 2014, Arquivos brasileiros de endocrinologia e metabologia.

[28]  R. Negro,et al.  Diagnosis and management of subclinical hypothyroidism in pregnancy , 2014, BMJ : British Medical Journal.

[29]  K. Lunetta,et al.  Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium. , 2014, Journal of the National Cancer Institute.

[30]  P. Taylor,et al.  TSH levels and risk of miscarriage in women on long-term levothyroxine: a community-based study. , 2014, The Journal of clinical endocrinology and metabolism.

[31]  N. Silanikove Natural and abrupt involution of the mammary gland affects differently the metabolic and health consequences of weaning. , 2014, Life sciences.

[32]  Sabrina L. Spencer,et al.  The Proliferation-Quiescence Decision Is Controlled by a Bifurcation in CDK2 Activity at Mitotic Exit , 2013, Cell.

[33]  R. Carón,et al.  Experimental hypothyroidism increases apoptosis in dimethylbenzanthracene-induced mammary tumors. , 2013, Oncology reports.

[34]  Á. Pascual,et al.  Thyroid hormone receptors, cell growth and differentiation. , 2013, Biochimica et biophysica acta.

[35]  Danielle G. Lemay,et al.  Epigenetic Modifications Unlock the Milk Protein Gene Loci during Mouse Mammary Gland Development and Differentiation , 2013, PloS one.

[36]  G. Brent,et al.  Mechanisms of thyroid hormone action. , 2012, The Journal of clinical investigation.

[37]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[38]  H. Hvid,et al.  Mammary gland proliferation in female rats: effects of the estrous cycle, pseudo-pregnancy and age. , 2012, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[39]  Cecilia J. Proietti,et al.  The molecular basis of progesterone receptor action in breast carcinogenesis , 2012, Hormone molecular biology and clinical investigation.

[40]  J. Russo,et al.  Pregnancy-Induced Changes in Breast Cancer Risk , 2011, Journal of Mammary Gland Biology and Neoplasia.

[41]  J. Russo,et al.  Exposure to the endocrine disruptor bisphenol A alters susceptibility for mammary cancer , 2011, Hormone molecular biology and clinical investigation.

[42]  J. Turkson,et al.  Stat3 controls lysosomal-mediated cell death in vivo , 2011, Nature Cell Biology.

[43]  Jeffrey M. Rosen,et al.  The Epigenetic Landscape of Mammary Gland Development and Functional Differentiation , 2010, Journal of Mammary Gland Biology and Neoplasia.

[44]  L. Boscá,et al.  Mice Lacking Thyroid Hormone Receptor β Show Enhanced Apoptosis and Delayed Liver Commitment for Proliferation after Partial Hepatectomy , 2010, PloS one.

[45]  M. Pibiri,et al.  Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype , 2009, Hepatology.

[46]  C. Watson Immune cell regulators in mouse mammary development and involution. , 2009, Journal of animal science.

[47]  Melissa A. Sandahl,et al.  Prolactin and ErbB4/HER4 signaling interact via Janus kinase 2 to induce mammary epithelial cell gene expression differentiation. , 2008, Molecular endocrinology.

[48]  R. Simpson Quantifying protein by bicinchoninic Acid. , 2008, CSH protocols.

[49]  J. Bernal Thyroid hormone receptors in brain development and function , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[50]  J. Russo,et al.  Differentiation of the mammary gland and susceptibility to carcinogenesis , 2005, Breast Cancer Research and Treatment.

[51]  M. C. Rudolph,et al.  Functional Development of the Mammary Gland: Use of Expression Profiling and Trajectory Clustering to Reveal Changes in Gene Expression During Pregnancy, Lactation, and Involution , 2003, Journal of Mammary Gland Biology and Neoplasia.

[52]  K. Darcy,et al.  A Developmental Atlas of Rat Mammary Gland Histology , 2000, Journal of Mammary Gland Biology and Neoplasia.

[53]  P. Unterberger,et al.  Cell Proliferation, Apoptosis, and Expression of Bcl-2 and Bax in Non-Lactating Human Breast Epithelium in Relation to the Menstrual Cycle and Reproductive History , 2004, Breast Cancer Research and Treatment.

[54]  M. Neville,et al.  Hormonal Regulation of Mammary Differentiation and Milk Secretion , 2004, Journal of Mammary Gland Biology and Neoplasia.

[55]  L. Hennighausen,et al.  An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. , 2002, Development.

[56]  D. Pfaff,et al.  Estrogen and thyroid hormone receptor interactions: physiological flexibility by molecular specificity. , 2002, Physiological reviews.

[57]  D. Pfaff,et al.  Crosstalk Between Oestrogen Receptors and Thyroid Hormone Receptor Isoforms Results in Differential Regulation of the Preproenkephalin Gene , 2001, Journal of neuroendocrinology.

[58]  D. Pfaff,et al.  Differential crosstalk between estrogen receptor (ER)alpha and ERbeta and the thyroid hormone receptor isoforms results in flexible regulation of the consensus ERE. , 2001, Brain research. Molecular brain research.

[59]  G. Potter,et al.  Thyroid hormone action in neural development. , 2000, Cerebral cortex.

[60]  V. S̆trbák,et al.  Thyroid hormones in milk: physiological approach--a review. , 1983, Endocrinologia experimentalis.

[61]  C. Lowe,et al.  Breast cancer and reproduction. , 1970, Lancet.

[62]  C. Lowe,et al.  Breast cancer and reproductive history of women in South Wales. , 1970, Lancet.

[63]  C. Lowe,et al.  Lactation and cancer of the breast. A summary of an international study. , 1970, Bulletin of the World Health Organization.

[64]  C. Lowe,et al.  Age at first birth and breast cancer risk. , 1970, Bulletin of the World Health Organization.

[65]  B. Macmahon,et al.  Lactation and reproductive histories of breast cancer patients in Tokyo, Japan. , 1970, Bulletin of the World Health Organization.

[66]  B. Macmahon,et al.  Lactation and reproductive histories of breast cancer patients in Boston, 1965-66. , 1969, Journal of the National Cancer Institute.

[67]  J. D. DA SILVEIRA [The thyroid hormone as complementary treatment in genital and mammary cancer]. , 1965, Revista de ginecologia e d'obstetricia.